Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
Medtronic
Dow
McKinsey

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Methylergonovine maleate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for methylergonovine maleate and what is the scope of patent protection?

Methylergonovine maleate is the generic ingredient in two branded drugs marketed by Edison Theraps Llc, Breckenridge, Luitpold, Amneal Pharms, Granules Pharms, Novel Labs Inc, and Teva Pharms Usa, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for methylergonovine maleate. Twelve suppliers are listed for this compound.

Recent Clinical Trials for methylergonovine maleate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brigham and Women's HospitalPhase 4
Johns Hopkins UniversityEarly Phase 1
University of California, San FranciscoPhase 4

See all methylergonovine maleate clinical trials

Pharmacology for methylergonovine maleate
Medical Subject Heading (MeSH) Categories for methylergonovine maleate
Synonyms for methylergonovine maleate
(8|A)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-ergoline-8-carbox-amide Maleate
[8?(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamide maleate
432M618
57432-61-8
7054-07-1
9,10-Didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methylergoline-8beta-carboxamide maleate (1:1) (salt)
9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8|A-carboxamide maleate salt
9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8beta-carboxamide maleate salt
AKOS024282479
AN-25473
B6347
C20H25N3O2
CCG-39168
CHEBI:6874
CHEMBL1200843
D00680
EINECS 260-734-4
Erezin
Erezingen
Ergoline-8-carboxamide, 9,10-didehydro-N-((1S)-1-(hydroxymethyl)propyl)-6-methyl-, (8beta)-, (2Z)-2-butenedioate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8-beta-(S))-,(Z)-2-butenedioate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(S))-, (Z)-2-butenedioate (1:1) (salt)
Ergonovine, methyl-, maleate (1:1)
EU-0100794
HMS1920N11
HMS2091F22
HMS2096K09
HMS3262O10
HMS3713K09
HMS501B19
IR84JPZ1RK
LP00794
LS-64364
M 2776
Maleic acid, methyl ergonovine
Metenarin
Methergin
Methergine
Methergine (TN)
Methergine maleate
Methergine maleate salt
Methyl Ergonovine Maleate Salt
Methylergobasine maleate
Methylergometrine for system suitability, European Pharmacopoeia (EP) Reference Standard
Methylergometrine maleate
Methylergometrine maleate (JP17)
Methylergometrine maleate, European Pharmacopoeia (EP) Reference Standard
Methylergonovine maleate (USP)
Methylergonovine maleate [USAN]
Methylergonovine maleate [USP]
Methylergonovine maleate salt
Methylergonovine maleate, United States Pharmacopeia (USP) Reference Standard
METHYLERGONOVINIUM BIMALEATE
MFCD00078588
MolPort-003-666-807
N-[|A-(Hydroxymethyl)propyl]-D-lysergamide Maleate
NCGC00261479-01
NSC-757104
NSC757104
Pharmakon1600-01500404
SCHEMBL239437
SPECTRUM1500404
ST056347
Tox21_500794
UNII-IR84JPZ1RK
USAF uctl-8

US Patents and Regulatory Information for methylergonovine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Granules Pharms METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 210424-001 May 15, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Breckenridge METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 040889-001 Sep 13, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Luitpold METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 090193-001 Nov 24, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Dow
Johnson and Johnson
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.